From the NEJM this week: One of the first studies showing that micromets are clinically significant (in a large retrospective series).
Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer: "This study involving women with early-stage breast cancer showed an association between the presence of isolated tumor cells or micrometastases in sentinel or axillary lymph nodes and the 5-year rate of disease-free survival. Women with such findings in these lymph nodes who received systemic adjuvant therapy had an improved outcome. "
Thursday, August 13, 2009
Subscribe to:
Post Comments (Atom)
1 comment:
This was an exciting study. now detection takes the forefront as the primary deficiency in our ability to treat breast cancer
Post a Comment